Targovax ASA, a HealthCap V portfolio company, announced a NOK 200 million private placement, with HealthCap V L.P. committing NOK 25 million. HealthCap is Targovax’s largest shareholder at 22%, fully diluted, after the placement and before a repair offering.
Alex Suh is a founding managing director at California Technology Ventures, LLC, a Southern California venture capital firm focused on life sciences and information technology.
Andrea DeVita is Director of Finance at California Technology Ventures, LLC and Jacobs Capital Group, LLC. She is responsible for all financial and operational activities, as well as assisting with business plan sourcing, due diligence, special projects, and assisting portfolio companies.
William A. Hanna is a Managing Director with California Technology Ventures, LLC and Jacobs Capital Group, LLC. He brings extensive experience and expertise in the financial and investment industries to the team.
The company is a venture capital fund of funds and also invests as a venture capitalist. It says its model does not limit investments to one sector, its local area, solo investments, or companies expected to return 10x.
The company seeks venture funds that share its vision and fit its investment principles, rather than investing solely for alpha. It says it is not a significant investor and may bring value to partner funds, and seeks fit or benefit across its partner-fund circle.